These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 33478790

  • 41. First 5 years of measles elimination in southern Africa: 1996-2000.
    Biellik R, Madema S, Taole A, Kutsulukuta A, Allies E, Eggers R, Ngcobo N, Nxumalo M, Shearley A, Mabuzane E, Kufa E, Okwo-Bele JM.
    Lancet; 2002 May 04; 359(9317):1564-8. PubMed ID: 12047966
    [Abstract] [Full Text] [Related]

  • 42. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
    Hayford K, Mutembo S, Carcelen A, Matakala HK, Munachoonga P, Winter A, Wanyiri JW, Searle K, Mwansa FD, Mwiche A, Phiri C, Book C, Thuma PE, Moss WJ.
    Vaccine; 2019 Apr 17; 37(17):2387-2393. PubMed ID: 30905529
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A, Boxall N, Amirthalingam G, Maddock L, Balasegaram S, Mindlin M.
    Vaccine; 2014 Feb 26; 32(10):1147-52. PubMed ID: 24440207
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Vaccinations and Vaccinators' Tracking System in Island Settlements: CHAD 2017-2018.
    Atagbaza A, Okeibunor J, Amadou F, Kalilou S, Esanga AM, Bagayoko AN, Bohoussou P, Igweonu O, Seid MM, Aliyu AJ, Ntezayabo EB, Traore MA, Nzioki M, Olaleye A, Aluma ADL, Sedick DA, Seid AM, Tahir MS, de Medeiros N, Rabenarivo B, Diomande F, Mkanda P.
    J Immunol Sci; 2021 Apr 12; Spec Issue(2):1116. PubMed ID: 33954308
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Sub-national variation in measles vaccine coverage and outbreak risk: a case study from a 2010 outbreak in Malawi.
    Kundrick A, Huang Z, Carran S, Kagoli M, Grais RF, Hurtado N, Ferrari M.
    BMC Public Health; 2018 Jun 15; 18(1):741. PubMed ID: 29902976
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. An evaluation of community perspectives and contributing factors to missed children during an oral polio vaccination campaign--Katsina State, Nigeria.
    Michael CA, Ashenafi S, Ogbuanu IU, Ohuabunwo C, Sule A, Corkum M, Mackay S, Storms AD, Achari P, Biya O, Nguku P, Newberry D, Bwaka A, Mahoney F, OPV Campaign Missed Children Study Team.
    J Infect Dis; 2014 Nov 01; 210 Suppl 1():S131-5. PubMed ID: 25316827
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Polio Legacy in Action: Using the Polio Eradication Infrastructure for Measles Elimination in Nigeria-The National Stop Transmission of Polio Program.
    Michael CA, Waziri N, Gunnala R, Biya O, Kretsinger K, Wiesen E, Goodson JL, Esapa L, Gidado S, Uba B, Nguku P, Cochi S.
    J Infect Dis; 2017 Jul 01; 216(suppl_1):S373-S379. PubMed ID: 28838182
    [Abstract] [Full Text] [Related]

  • 56. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR, Choe YJ, Go UY, Kim YI, Lee JK.
    Vaccine; 2013 May 31; 31(24):2661-6. PubMed ID: 23602654
    [Abstract] [Full Text] [Related]

  • 57. Sustainable Development Goals and childhood measles vaccination in Ekiti State, Nigeria: Results from spatial and interrupted time series analyses.
    Ilesanmi MM, Adeyinka DA, Olakunde BO.
    Vaccine; 2022 Jun 21; 40(28):3861-3868. PubMed ID: 35644673
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Demographics, epidemiology and the impact of vaccination campaigns in a measles-free world - Can elimination be maintained?
    Prada JM, Metcalf CJE, Takahashi S, Lessler J, Tatem AJ, Ferrari M.
    Vaccine; 2017 Mar 13; 35(11):1488-1493. PubMed ID: 28216186
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.